Neurogenic Cells

Neurogenic (neural-lineage) cells are directed toward neuronal and glial phenotypes and are studied in neurodegenerative and neurodevelopmental contexts.

How Neurogenic Cells are used

The therapeutic value of Neurogenic Cells lies less in cells "becoming" new tissue and more in their paracrine signalling — the growth factors and vesicles they release to calm inflammation and recruit the body's own repair. Delivery is matched to the target: intravenous for systemic conditions, or localised where appropriate.

Conditions where Neurogenic Cells feature

Quality & safety

• GMP-certified preparation in the European Union
• Characterised, viability-tested cells from a certified bank
• Personalised dosing within a physician-led protocol
• Transparent pricing — €3,000–€8,000 per programme

Educational information. Neurogenic Cells protocols for several conditions remain investigational; outcomes vary by patient.